Implications for fracture healing of current and new osteoporosis treatments: An ESCEO consensus paper

Calcified Tissue International

Volumn 90, Issue 5, 2012, Pages 343-353

  Goldhahn, J ^a   Feron J M ^b   Kanis, J ^c   Papapoulos, S ^d   Reginster, J Y ^e   Rizzoli, R ^f   Dere, W ^g   Mitlak, B ^h   Tsouderos, Y ⁱ   Boonen, S ^j  

^a ETH ZURICH   (Switzerland)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g AMGEN LTD   (United Kingdom)

^h ELI LILLY AND COMPANY   (United States)

ⁱ INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^j UNIVERSITY OF LEUVEN   (Belgium)

more..

Author keywords

Bone formation; Fractures; Healing; Osteoporosis; Treatment

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN; CLODRONIC ACID; DENOSUMAB; DICKKOPF 1 PROTEIN; DICKKOPF 1 PROTEIN ANTIBODY; IBANDRONIC ACID; INCADRONIC ACID; PAMIDRONIC ACID; PARATHYROID HORMONE[1-34]; PLACEBO; PROTEIN ANTIBODY; RALOXIFENE; RECOMBINANT PARATHYROID HORMONE; RISEDRONIC ACID; SCLEROSTIN; STRONTIUM RANELATE; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

BONE DENSITY; BONE MINERAL; BONE MINERALIZATION; BONE REMODELING; BONE STRENGTH; BONE STRUCTURE; CALLUS; CONSENSUS DEVELOPMENT; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; FRACTURE HEALING; HUMAN; NONHUMAN; OSSIFICATION; OSTEOPOROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; BONE DENSITY CONSERVATION AGENTS; FRACTURE HEALING; FRACTURES, BONE; HUMANS; OSTEOPOROSIS; TERIPARATIDE;

EID: 84859899926     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-012-9587-4     Document Type: Review

References (73)

1. J Goldhahn M Blauth 2007 Osteoporotic fracture management: closing the gap of knowledge Arch Orthop Trauma Surg 127 1 2 17151851 10.1007/s00402-006- 0262-y 1:STN:280:DC%2BD28jjvFGqtw%3D%3D (Pubitemid 44964027)
2. J Goldhahn N Suhm S Goldhahn, et al. 2008 Influence of osteoporosis on fracture fixation-a systematic literature review Osteoporos Int 19 761 772 18066697 10.1007/s00198-007-0515-9 1:STN:280:DC%2BD1crotFylug%3D%3D
3. CN Cornell 2003 Internal fracture fixation in patients with osteoporosis J Am Acad Orthop Surg 11 109 119 12670137
4. P Aspenberg 2005 Drugs and fracture repair Acta Orthop 76 741 748 16470424 10.1080/17453670510045318
5. JE Yates S Hadi Shah JC Blackwell 2011 Clinical inquiries: do NSAIDs impede fracture healing? J Fam Pract 60 41 42 21209979
6. J Goldhahn B Mitlak P Aspenberg, et al. 2008 Critical issues in translational and clinical research for the study of new technologies to enhance bone repair J Bone Joint Surg Am 90 Suppl 1 43 47 18292356 10.2106/JBJS.G.01090 (Pubitemid 351329120)
7. J Goldhahn WH Scheele BH Mitlak, et al. 2008 Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis Bone 43 343 347 18544475 10.1016/j.bone.2008.04.017
8. S Goldhahn T Sawaguchi L Audige, et al. 2009 Complication reporting in orthopaedic trials: a systematic review of randomized controlled trials J Bone Joint Surg Am 91 1847 1853 19651940 10.2106/JBJS.H.01455 1:STN:280: DC%2BD1Mrjt1emtA%3D%3D
9. S Goldhahn F Kralinger D Rikli, et al. 2010 Does osteoporosis increase complication risk in surgical fracture treatment? A protocol combining new endpoints for two prospective multicentre open cohort studies BMC Musculoskelet Disord 11 256 21062463 10.1186/1471-2474-11-256
10. S Morshed M Bhandari 2008 Clinical trial design in fracture-healing research: meeting the challenge J Bone Joint Surg Am 90 Suppl 1 55 61 18292358 10.2106/JBJS.G.01478 (Pubitemid 351329122)
11. J Goldhahn D Little P Mitchell, et al. 2010 Evidence for anti-osteoporosis therapy in acute fracture situations-recommendations of a multidisciplinary workshop of the International Society for Fracture Repair Bone 46 267 271 19833244 10.1016/j.bone.2009.10.004 1:STN:280:DC%2BC3c7gs1Cguw%3D%3D
12. H Fleisch 2001 Can bisphosphonates be given to patients with fractures? J Bone Miner Res 16 437 440 11277260 10.1359/jbmr.2001.16.3.437 1:CAS:528:DC%2BD3MXhvFKksbk%3D (Pubitemid 32173357)
13. P Aspenberg 2009 Bisphosphonates and implants: an overview Acta Orthop 80 119 123 19234893 10.1080/17453670902807466
14. Y Cao S Mori T Mashiba, et al. 2002 Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats J Bone Miner Res 17 2237 2246 12469918 10.1359/jbmr.2002.17.12.2237 1:CAS:528:DC%2BD38XpsV2lsb4%3D (Pubitemid 35416758)
15. N Amanat M McDonald C Godfrey, et al. 2007 Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair J Bone Miner Res 22 867 876 17371160 10.1359/jbmr.070318 1:CAS:528:DC%2BD2sXpt12jtr0%3D (Pubitemid 351339747)
16. BA Lenart DG Lorich JM Lane 2008 Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate N Engl J Med 358 1304 1306 18354114 10.1056/NEJMc0707493 1:CAS:528:DC%2BD1cXjvVarsb8%3D (Pubitemid 351439247)
17. CV Odvina JE Zerwekh DS Rao, et al. 2005 Severely suppressed bone turnover: a potential complication of alendronate therapy J Clin Endocrinol Metab 90 1294 1301 15598694 10.1210/jc.2004-0952 1:CAS:528:DC%2BD2MXisVOhsr0%3D (Pubitemid 40463979)
18. R Rizzoli K Akesson M Bouxsein, et al. 2011 Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report Osteoporos Int 22 373 390 21085935 10.1007/s00198-010-1453-5 1:CAS:528:DC%2BC3MXmtFWmsA%3D%3D
19. LC Gerstenfeld DJ Sacks M Pelis, et al. 2009 Comparison of effects of the bisphosphonate alendronate vs. the RANKL inhibitor denosumab on murine fracture healing J Bone Miner Res 24 196 208 19016594 10.1359/jbmr.081113 1:CAS:528:DC%2BD1MXitlWktrk%3D
20. RW Boyce CL Paddock JR Gleason, et al. 1995 The effects of risedronate on canine cancellous bone remodeling: three-dimensional kinetic reconstruction of the remodeling site J Bone Miner Res 10 211 221 7754801 10.1002/jbmr.5650100207 1:CAS:528:DyaK2MXmslSktL8%3D
21. N Amanat R Brown LE Bilston, et al. 2005 A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair J Orthop Res 23 1029 1034 16140188 10.1016/j.orthres.2005.03.004 1:CAS:528:DC%2BD2MXpslygsLo%3D (Pubitemid 41245425)
22. J Li S Mori Y Kaji, et al. 2000 Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats J Bone Miner Res 15 2042 2051 11028459 10.1359/jbmr.2000.15.10.2042 1:STN:280:DC%2BD3cvnslSruw%3D%3D
23. J Li S Mori Y Kaji, et al. 1999 Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats J Bone Miner Res 14 969 979 10352106 10.1359/jbmr.1999.14.6.969 1:CAS:528:DyaK1MXjvFKqur0%3D (Pubitemid 29262892)
24. P Tengvall B Skoglund A Askendal, et al. 2004 Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats Biomaterials 25 2133 2138 14741628 10.1016/j.biomaterials.2003.08.049 1:CAS:528: DC%2BD2cXktlahtA%3D%3D (Pubitemid 38102413)
25. B Skoglund J Holmertz P Aspenberg 2004 Systemic and local ibandronate enhance screw fixation J Orthop Res 22 1108 1113 15304286 10.1016/j.orthres. 2003.12.015 1:CAS:528:DC%2BD2cXmsVKhsbc%3D (Pubitemid 39145130)
26. KW Lyles CS Colon-Emeric JS Magaziner, et al. 2007 Zoledronic acid and clinical fractures and mortality after hip fracture N Engl J Med 357 1799 1809 17878149 10.1056/NEJMoa074941 1:CAS:528:DC%2BD2sXht1Kit7nN (Pubitemid 350044800)
27. C Colon-Emeric L Nordsletten S Olson, et al. 2011 Association between timing of zoledronic acid infusion and hip fracture healing Osteoporos Int 22 2329 2336 21153021 10.1007/s00198-010-1473-1 1:CAS:528:DC%2BC3MXoslaqsbw%3D
28. van der Poest CE, van EM, Ader H, et al. (2002) Alendronate in the prevention of bone loss after a fracture of the lower leg. J Bone Miner Res 17:2247-2255 (Pubitemid 35416759)
29. CE van der Poest P Patka K Vandormael, et al. 2000 The effect of alendronate on bone mass after distal forearm fracture J Bone Miner Res 15 586 593 (Pubitemid 30134104)
30. CF Munns F Rauch L Zeitlin, et al. 2004 Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate J Bone Miner Res 19 1779 1786 15476577 10.1359/JBMR.040814 1:CAS:528:DC%2BD2cXhtVSltLnJ (Pubitemid 41103428)
31. P Pulkkinen F Eckstein EM Lochmuller, et al. 2006 Association of geometric factors and failure load level with the distribution of cervical vs. trochanteric hip fractures J Bone Miner Res 21 895 901 16753020 10.1359/jbmr.060305 (Pubitemid 43787996)
32. DH Solomon MC Hochberg H Mogun, et al. 2009 The relation between bisphosphonate use and non-union of fractures of the humerus in older adults Osteoporos Int 20 895 901 18843515 10.1007/s00198-008-0759-z 1:CAS:528:DC%2BD1MXls12ktrc%3D
33. A Moroni C Faldini A Hoang-Kim, et al. 2007 Alendronate improves screw fixation in osteoporotic bone J Bone Joint Surg Am 89 96 101 17200316 10.2106/JBJS.F.00484 (Pubitemid 46059148)
34. M Hilding P Aspenberg 2007 Local peroperative treatment with a bisphosphonate improves the fixation of total knee prostheses: a randomized, double-blind radiostereometric study of 50 patients Acta Orthop 78 795 799 18236186 10.1080/17453670710014572 (Pubitemid 351185601)
35. M Hilding P Aspenberg 2006 Postoperative clodronate decreases prosthetic migration: 4-year follow-up of a randomized radiostereometric study of 50 total knee patients Acta Orthop 77 912 916 17260200 10.1080/17453670610013213
36. Adami S, Adachi J, Boonen S, et al. (2010) Denosumab administration is not associated with fracture healing complications in postmenopausal women with osteoporosis: results from the FREEDOM trial. J Bone Miner Res 25 Suppl 1:MO0405
37. EK Stuermer S Sehmisch T Rack, et al. 2010 Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis. A new fracture-healing model at the tibia in rat Langenbecks Arch Surg 395 163 172 19048282 10.1007/s00423-008-0436-x 1:STN:280:DC%2BC3c%2FmsVCntQ%3D%3D
38. SV Bukata JE Puzas 2010 Orthopedic uses of teriparatide Curr Osteoporos Rep 8 28 33 20425088 10.1007/s11914-010-0006-3
39. TT Andreassen C Ejersted H Oxlund 1999 Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures J Bone Miner Res 14 960 968 10352105 10.1359/jbmr.1999.14.6.960 1:CAS:528:DyaK1MXjvFKqurw%3D (Pubitemid 29262891)
40. TT Andreassen C Fledelius C Ejersted, et al. 2001 Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone Acta Orthop Scand 72 304 307 11480610 10.1080/ 00016470152846673 1:STN:280:DC%2BD3MvjtlCjsA%3D%3D (Pubitemid 32613496)
41. Holzer G, Majeska RJ, Lundy MW, et al. (1999) Parathyroid hormone enhances fracture healing: a preliminary report. Clin Orthop Relat Res 258-263 (Pubitemid 29439363)
42. A Nakajima N Shimoji K Shiomi, et al. 2002 Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34) J Bone Miner Res 17 2038 2047 12412812 10.1359/jbmr.2002.17.11.2038 1:CAS:528:DC%2BD38Xoslems7k%3D (Pubitemid 35239205)
43. JS Jahng HW Kim 2000 Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats Orthopedics 23 1089 1094 11045557 1:STN:280:DC%2BD3crgtVWkuw%3D%3D
44. SJ Warden DE Komatsu J Rydberg, et al. 2009 Recombinant human parathyroid hormone (PTH 1-34) and low-intensity pulsed ultrasound have contrasting additive effects during fracture healing Bone 44 485 494 19071238 10.1016/j.bone.2008.11.007 1:CAS:528:DC%2BD1MXhvF2qsbY%3D
45. MP Bostrom SC Gamradt P Asnis, et al. 2000 Parathyroid hormone-related protein analog RS-66271 is an effective therapy for impaired bone healing in rabbits on corticosteroid therapy Bone 26 437 442 10773582 10.1016/S8756- 3282(00)00251-9 1:CAS:528:DC%2BD3cXisFGrur0%3D (Pubitemid 30204463)
46. YM Alkhiary LC Gerstenfeld E Krall, et al. 2005 Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34) J Bone Joint Surg Am 87 731 741 15805200 10.2106/JBJS.D.02115 (Pubitemid 40489347)
47. S Kakar TA Einhorn S Vora, et al. 2007 Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures J Bone Miner Res 22 1903 1912 17680724 10.1359/jbmr.070724 1:CAS:528:DC%2BD2sXhsVyjtrnO (Pubitemid 351229307)
48. O'Loughlin PF, Cunningham ME, Bukata SV, et al. (2009) Parathyroid hormone (1-34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model. Spine (Phila Pa 1976) 34:121-130
49. RA Lehman Jr AE Dmitriev MJ Cardoso, et al. 2010 Effect of teriparatide [rhPTH(1,34)] and calcitonin on intertransverse process fusion in a rabbit model Spine 35 146 152 20081509 10.1097/BRS.0b013e3181b71a96
50. R Skripitz P Aspenberg 2001 Implant fixation enhanced by intermittent treatment with parathyroid hormone J Bone Joint Surg Br 83 437 440 11341434 10.1302/0301-620X.83B3.10256 1:STN:280:DC%2BD3MzgvFKnug%3D%3D (Pubitemid 32390361)
51. DG Reynolds M Takahata AL Lerner, et al. 2011 Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model Bone 48 562 570 20950720 10.1016/j.bone.2010.10.003 1:CAS:528:DC%2BC3MXhvFWgurY%3D
52. TP Knecht 2004 Teriparatide and fracture healing in cortical bone Endocr Pract 10 293 15382326
53. PT Rubery SV Bukata 2010 Teriparatide may accelerate healing in delayed unions of type III odontoid fractures: a report of 3 cases J Spinal Disord Tech 23 151 155 20051918 10.1097/BSD.0b013e31819a8b7a
54. CT Yu JK Wu CC Chang, et al. 2008 Early callus formation in human hip fracture treated with internal fixation and teriparatide J Rheumatol 35 2082 2083 18843769
55. P Aspenberg HK Genant T Johansson, et al. 2010 Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures J Bone Miner Res 25 404 414 19594305 10.1359/jbmr.090731 1:CAS:528: DC%2BC3cXksl2ksLg%3D
56. P Aspenberg T Johansson 2010 Teriparatide improves early callus formation in distal radial fractures Acta Orthop 81 234 236 20367417 10.3109/ 17453671003761946
57. JD Bashutski RM Eber JS Kinney, et al. 2010 Teriparatide and osseous regeneration in the oral cavity N Engl J Med 363 2396 2405 20950166 10.1056/NEJMoa1005361 1:CAS:528:DC%2BC3cXhsF2ltLfO
58. P Peichl LA Holzer R Maier G Holzer 2011 Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women J Bone Joint Surg Am 93 1583 1587 21915572 10.2106/JBJS.J.01379
59. YF Li E Luo G Feng, et al. 2009 Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats Osteoporos Int 21 1889 1897 19957162 10.1007/s00198-009-1140-6
60. KE Ozturan B Demir I Yucel, et al. 2011 Effect of strontium ranelate on fracture healing in the osteoporotic rats J Orthop Res 29 138 142 20726035 10.1002/jor.21204 1:CAS:528:DC%2BC3MXktVahsA%3D%3D
61. B Habermann K Kafchitsas G Olender, et al. 2010 Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing Calcif Tissue Int 86 82 89 19960189 10.1007/s00223-009-9317-8 1:CAS:528:DC%2BC3cXit1Knsw%3D%3D
62. O Cebesoy E Tutar KC Kose, et al. 2007 Effect of strontium ranelate on fracture healing in rat tibia Joint Bone Spine 74 590 593 17967557 10.1016/j.jbspin.2007.01.034 (Pubitemid 350236018)
63. L Maimoun T Brennan I Badoud, et al. 2010 Strontium ranelate improves implant osseointegration Bone 46 1436 1441 20116464 10.1016/j.bone.2010.01.379 1:CAS:528:DC%2BC3cXksFClu7g%3D
64. Y Li G Feng Y Gao, et al. 2010 Strontium ranelate treatment enhances hydroxyapatite-coated titanium screws fixation in osteoporotic rats J Orthoped Res 28 578 582 1:CAS:528:DC%2BC3cXmtVCjtb8%3D
65. DN Alegre C Ribeiro C Sousa, et al. 2012 Possible benefits of strontium ranelate in complicated long bone fractures Rheumatol Int 32 439 443 21120486 10.1007/s00296-010-1687-8
66. U Tarantino M Celi L Saturnino, et al. 2010 Strontium ranelate and bone healing: report of two cases Clin Cases Miner Bone Metab 7 65 68 22461295
67. X Li MS Ominsky KS Warmington, et al. 2009 Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis J Bone Miner Res 24 578 588 19049336 10.1359/jbmr.081206 1:CAS:528:DC%2BD1MXksF2lu7c%3D
68. F Agholme X Li H Isaksson, et al. 2010 Sclerostin antibody treatment enhances metaphyseal bone healing in rats J Bone Miner Res 25 2412 2418 20499342 10.1002/jbmr.135 1:CAS:528:DC%2BC3cXhsVOjtbzJ
69. FJ Secreto LH Hoeppner JJ Westendorf 2009 Wnt signaling during fracture repair Curr Osteoporos Rep 7 64 69 19631031 10.1007/s11914-009-0012-5
70. Y Chen HC Whetstone AC Lin, et al. 2007 Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing PLoS Med 4 e249 17676991 10.1371/journal.pmed.0040249 (Pubitemid 47196225)
71. DE Komatsu MN Mary RJ Schroeder, et al. 2010 Modulation of Wnt signaling influences fracture repair J Orthop Res 28 928 936 20063381 1:CAS:528: DC%2BC3cXosFelsrs%3D
72. Garrison KR, Shemilt I, Donell S, et al. (2010) Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst Rev CD006950
73. C Tzioupis PV Giannoudis 2007 Prevalence of long-bone non-unions Injury 38 Suppl 2 S3 S9 17920415 10.1016/S0020-1383(07)80003-9